Achieve Life Sciences, Inc. (ACHV) Stock Overview
Explore Achieve Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Achieve Life Sciences, Inc. (ACHV)
Key Financials
Key Financials
Market Cap
871.6M
P/E Ratio
-5.48
EPS (TTM)
$-1.55
ROE
-8.92%
ACHV Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Achieve Life Sciences, Inc. (NASDAQ: ACHV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Achieve Life Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ACHV on the NASDAQ shows an RSI of 67.39, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.13 for the NASDAQ listing.
Key metrics behind Achieve Life Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -5.48 and a market capitalization of 871.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACHV on the NASDAQ.